A proposed Office of Management and Budget (OMB) rule could materially change how federal agencies evaluate research integrity in funding decisions. If finalized, the rule would make research integrity a visible indicator of institutional funding readiness, not merely a post-award compliance expectation. The practical question for research institutions is no longer whether they have policies on paper, but whether they can demonstrate at the funding application stage that those policies operate effectively across the research lifecycle.
The OMB published the proposed rule “Regulation for Federal Financial Assistance” on May 29, 2026.[1] The proposal would require research institutions to show not only that individual funding applications are scientifically meritorious, but also that the institution has credible systems to support rigorous, reproducible, transparent, and accountable research. If finalized, that shift could affect how institutions prepare grant applications, monitor funded projects, evaluate investigator practices, manage allegations, oversee collaborators, and document the reliability of the broader research enterprise.
For institutional leaders, the proposal creates both a risk-management challenge and a market signal. Research integrity programs that have historically been evaluated after a problem arises may now need to become visible before funding is awarded, with evidence that governance, data controls, investigation processes, and corrective-action systems are functioning in practice.
Research integrity failures often appear first as individual misconduct allegations, questioned data, reporting irregularities, unsupported research conclusions, and authorship disputes. Those events frequently expose broader institutional weaknesses: weak data controls, inadequate supervision, fragmented compliance functions, unclear escalation pathways, and insufficient corrective action. Institutions which identify, document, and remediate those systemic weaknesses will be best positioned when research integrity becomes a more visible funding criterion.
Research Integrity Would Become a Funding Risk Issue, Not Just a Compliance Issue
The OMB proposal directs agencies to prioritize institutions demonstrating rigorous and reproducible scholarship, weigh institutional commitment to research integrity, and incorporate “Gold Standard Science” principles into award reviews.
For researchers, this may mean the quality of the institutional research environment becomes part of the funding narrative. A scientifically robust proposal may be less competitive if the institution cannot show that the work will be conducted within a reliable, well-governed research infrastructure. Grant submissions may therefore need stronger documentation of reproducibility, data quality, and oversight. Institutions may need to demonstrate enterprise-level controls rather than relying on investigator-level excellence alone.
Agencies Could Compare Institutions Based on the Reliability of Their Research Environment
The proposal does not simply ask whether a project is scientifically strong. Rather, it directs agencies to consider whether the applicant institution has the infrastructure needed to produce trustworthy research. As a result, institutional reputation and history could become more visible in award decisions. Institutions with mature research integrity programs may gain a competitive advantage, while institutions with more fragmented research integrity programs may face heightened scrutiny. Research administration, compliance, and legal leadership will need a more integrated view of research risk.
‘Gold Standard Science’ and Reproducibility Would Require Operational Proof
The proposal’s reference to rigorous, reproducible scholarship and “Gold Standard Science” principles is likely to push institutions toward more concrete evidence of research quality. Agencies may look for practices showing that research findings can be trusted, replicated, and defended. Important practices to have in place include data management and retention, statistical and analytical controls, and independent quality reviews for high-risk studies.
Institutional Research Integrity Programs Would Need to Become More Measurable
In principle, emphasis on research integrity is positive. However, the proposal provides limited operational guidance regarding measurement standards, institutional evaluation criteria, evidentiary thresholds, or any appeals processes. This creates significant uncertainty regarding how institutions will be assessed and compared. However, institutions should not wait for a final checklist. Instead, they should begin identifying the evidence they would use to demonstrate that their research integrity programs are working in practice.
What Researchers Should Expect
Researchers should expect that proving the integrity of their work throughout the grant lifecycle will become more consequential. Applications may need to describe data quality controls, reproducibility methods, protocol governance, and publication or correction practices more explicitly. Investigators may also face more institutional review before submission, particularly for high-risk studies, multi-site or foreign collaborations, or projects in fields likely to attract heightened scrutiny such as applied virology or health disparities. The practical message is that scientific merit will still matter, but it may no longer be enough by itself. Researchers will need to show that their work is designed, conducted, recorded, analyzed, and reported in a way that can withstand sponsor review.
What Research Institutions Should Do Now
Even before the proposed rule is finalized, there are practical steps institutions can take to assess whether their research integrity programs are ready to withstand greater scrutiny.
- Inventory the institution’s research integrity infrastructure, including misconduct procedures, responsible conduct of research training, data governance and security, conflict of interest controls, publication policies and authorship standards, and subrecipient oversight.
- Develop objective evidence of program effectiveness, such as investigation timeliness, training completion, independent review or quality checks, corrective action closure, data management and retention compliance, and escalation patterns.
- Build proposal-ready language that explains how the institution supports rigorous, reproducible, and transparent research.
- Identify high-risk research areas where additional statistical review, data-management controls, or independent monitoring is appropriate.
- Prepare leadership, principal investigators, research administration, compliance, and legal teams for more integrated pre-award review.
Research Integrity Funding Readiness should include evidence across seven core areas:
- governance and accountability;
- data integrity and reproducibility controls;
- misconduct allegation intake, investigation, and corrective action;
- training and investigator support;
- conflict, authorship, publication, and correction controls;
- subrecipient and collaborator oversight;
- evidence of program effectiveness.
Bottom Line
The institutions best positioned for this funding environment will be those that prove their research is appropriately governed, documented, and responsive to concerns regarding possible misconduct. Research institutions should act now to ensure that research integrity policies and procedures will translate into demonstrable operating evidence. Investigators must recognize that although scientific merit remains essential, funding agencies will increasingly expect proof that the research environment itself is reliable.
Notes
[1] https://www.federalregister.gov/documents/2026/05/29/2026-10817/regulation-for-federal-financial-assistance
© Copyright 2026. The views expressed herein are those of the author(s) and not necessarily the views of Ankura Consulting Group, LLC, its management, its subsidiaries, its affiliates, or its other professionals. Ankura is not a law firm and cannot provide legal advice.
